| Report ID | 276559 |
| Drug Identification Number | 02506297 |
| Brand name | APO-SITAGLIPTIN/METFORMIN XR |
| Common or Proper name | SITAGLIPTIN/METFORMIN XR |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 100MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30 BTL |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-01-20 |
| Estimated end date | 2026-02-13 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-23 |
| Company comments | 100 BTL available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-01-23 | French | Compare |
| v1 | 2026-01-23 | English | Compare |
Showing 1 to 2 of 2